222 related articles for article (PubMed ID: 34361031)
1. A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome.
van de Water RB; Krijgsman D; Houvast RD; Vahrmeijer AL; Kuppen PJK
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361031
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
3. Correlation between human leukocyte antigen-G expression and clinical parameters in oral squamous cell carcinoma.
Shen X; Wang P; Dai P; Jin B; Tong Y; Lin H; Shi G
Indian J Cancer; 2018; 55(4):340-343. PubMed ID: 30829267
[TBL] [Abstract][Full Text] [Related]
4. HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.
Zeestraten EC; Reimers MS; Saadatmand S; Goossens-Beumer IJ; Dekker JW; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jan; 110(2):459-68. PubMed ID: 24196788
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen-G in gynaecological tumours.
Guo X; Zhang J; Shang J; Cheng Y; Tian S; Yao Y
Int J Immunogenet; 2023 Aug; 50(4):163-176. PubMed ID: 37415092
[TBL] [Abstract][Full Text] [Related]
7. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
8. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.
Babay W; Ben Yahia H; Boujelbene N; Zidi N; Laaribi AB; Kacem D; Ben Ghorbel R; Boudabous A; Ouzari HI; Rizzo R; Rebmann V; Mrad K; Zidi I
Hum Immunol; 2018 Jun; 79(6):463-470. PubMed ID: 29499226
[TBL] [Abstract][Full Text] [Related]
10. The analysis of human leukocyte antigen-G level in patients with endometrial cancer by Western blot technique.
Walentowicz-Sadlecka M; Dziobek K; Grabiec M; Sadlecki P; Walentowicz P; Mak P; Szymankiewicz M; Kwinta P; Dutsch-Wicherek M
Am J Reprod Immunol; 2019 Jan; 81(1):e13070. PubMed ID: 30414280
[TBL] [Abstract][Full Text] [Related]
11. HLA-G expression in human ovarian carcinoma counteracts NK cell function.
Lin A; Yan WH; Xu HH; Gan MF; Cai JF; Zhu M; Zhou MY
Ann Oncol; 2007 Nov; 18(11):1804-9. PubMed ID: 17846022
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation.
Jørgensen N; Sayed A; Jeppesen HB; Persson G; Weisdorf I; Funck T; Hviid TVF
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560316
[TBL] [Abstract][Full Text] [Related]
13. High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.
Ullah M; Azazzen D; Kaci R; Benabbou N; Pujade Lauraine E; Pocard M; Mirshahi M
Neoplasia; 2019 Mar; 21(3):331-342. PubMed ID: 30802770
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma.
Ramos CS; Gonçalves AS; Marinho LC; Gomes Avelino MA; Saddi VA; Lopes AC; Simões RT; Wastowski IJ
Hum Immunol; 2014 Jul; 75(7):667-72. PubMed ID: 24759678
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.
Lin A; Yan WH
Front Immunol; 2018; 9():2164. PubMed ID: 30319626
[TBL] [Abstract][Full Text] [Related]
16. HLA-G regulators in cancer medicine: an outline of key requirements.
Zidi I; Ben Amor N
Tumour Biol; 2011 Dec; 32(6):1071-86. PubMed ID: 21792710
[TBL] [Abstract][Full Text] [Related]
17. Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer.
Dong DD; Yie SM; Li K; Li F; Xu Y; Xu G; Song L; Yang H
Hum Immunol; 2012 Oct; 73(10):998-1004. PubMed ID: 22841927
[TBL] [Abstract][Full Text] [Related]
18. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.
Wiśniewski A; Kowal A; Wyrodek E; Nowak I; Majorczyk E; Wagner M; Pawlak-Adamska E; Jankowska R; Ślesak B; Frydecka I; Kuśnierczyk P
Tissue Antigens; 2015 Jun; 85(6):466-75. PubMed ID: 25855135
[TBL] [Abstract][Full Text] [Related]
20. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
